|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
2006-11-8
|
|
pubmed:abstractText |
An adult trial reported the efficacy of recombinant human erythropoietin in critically ill patients with a 19% decrease in red blood cell transfusion. Our aim was to evaluate the relevance of this prophylactic treatment in children hospitalized in a pediatric intensive care unit (PICU).
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Nov
|
|
pubmed:issn |
1529-7535
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
7
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
541-4
|
|
pubmed:dateRevised |
2011-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:17006380-Adolescent,
pubmed-meshheading:17006380-Child,
pubmed-meshheading:17006380-Child, Preschool,
pubmed-meshheading:17006380-Cohort Studies,
pubmed-meshheading:17006380-Erythrocyte Transfusion,
pubmed-meshheading:17006380-Erythropoietin,
pubmed-meshheading:17006380-Female,
pubmed-meshheading:17006380-Hemoglobins,
pubmed-meshheading:17006380-Hospitals, University,
pubmed-meshheading:17006380-Humans,
pubmed-meshheading:17006380-Infant,
pubmed-meshheading:17006380-Intensive Care Units, Pediatric,
pubmed-meshheading:17006380-Male,
pubmed-meshheading:17006380-Recombinant Proteins
|
|
pubmed:year |
2006
|
|
pubmed:articleTitle |
Is a prophylactic treatment by erythropoietin relevant to reduce red blood cell transfusion in the pediatric intensive care unit?
|
|
pubmed:affiliation |
Pediatric Intensive Care Unit, University Hospital of Nantes, Nantes, France.
|
|
pubmed:publicationType |
Journal Article
|
